A Phase # Clinical Study Trial of Felbinac Trometamol Injection in China

PHASE3CompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

July 23, 2021

Primary Completion Date

January 19, 2022

Study Completion Date

June 30, 2022

Conditions
Pain
Interventions
DRUG

Felbinac Trometamol Injection

"Felbinac Trometamol Injection diluted to 100 ml with 0.9% sodium chloride injection.Use a micro-injection pump to inject intravenously at a constant speed for 30 min (± 2 min)..~One dose at 8h and 16h after the start of the first dose,the first intravenous infusion was started at 30±5 minutes before the end of the operation (Skin suture completes the last stitch).The drug was given 3 times,3 times/day, once every 8 hours."

DRUG

Placebos

"Placebo diluted to 100 ml with 0.9% sodium chloride injection. Use a micro-injection pump to inject intravenously at a constant speed for 30 min (± 2 min).~One dose at 8h and 16h after the start of the first dose, the first intravenous infusion was started at 30±5 minutes before the end of the operation (Skin suture completes the last stitch).The drug was given 3 times,3 times/day, once every 8 hours."

Trial Locations (1)

050036

Shijiazhuang Yiling Pharmaceutical Co.,Ltd, Shijiazhuang

All Listed Sponsors
lead

Shijiazhuang Yiling Pharmaceutical Co. Ltd

INDUSTRY

NCT05297669 - A Phase # Clinical Study Trial of Felbinac Trometamol Injection in China | Biotech Hunter | Biotech Hunter